[go: up one dir, main page]

WO2004037987A3 - Proteines secretees - Google Patents

Proteines secretees Download PDF

Info

Publication number
WO2004037987A3
WO2004037987A3 PCT/US2003/033491 US0333491W WO2004037987A3 WO 2004037987 A3 WO2004037987 A3 WO 2004037987A3 US 0333491 W US0333491 W US 0333491W WO 2004037987 A3 WO2004037987 A3 WO 2004037987A3
Authority
WO
WIPO (PCT)
Prior art keywords
secp
secreted proteins
polynucleotides
agonists
diagnosing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2003/033491
Other languages
English (en)
Other versions
WO2004037987A2 (fr
Inventor
Mariah R Baughn
Shanya D Becha
Umesh G Bhatia
Julie J Blake
John D Burrill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Corp filed Critical Incyte Corp
Priority to AU2003286581A priority Critical patent/AU2003286581A1/en
Publication of WO2004037987A2 publication Critical patent/WO2004037987A2/fr
Publication of WO2004037987A3 publication Critical patent/WO2004037987A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Dans divers modes de réalisation, l'invention concerne des protéines humaines sécrétées (SECP) et des polynucléotides qui identifient et codent pour les SECP. Ces modes de réalisation comprennent aussi des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes. Dans d'autres modes de réalisation, l'invention concerne des procédés pour diagnostiquer, traiter ou prévenir les troubles associés à l'expression aberrante des SECP.
PCT/US2003/033491 2002-10-22 2003-10-22 Proteines secretees Ceased WO2004037987A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003286581A AU2003286581A1 (en) 2002-10-22 2003-10-22 Secreted proteins

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
US42072002P 2002-10-22 2002-10-22
US60/420,720 2002-10-22
US42520702P 2002-11-07 2002-11-07
US60/425,207 2002-11-07
US42667902P 2002-11-15 2002-11-15
US60/426,679 2002-11-15
US42787102P 2002-11-19 2002-11-19
US60/427,871 2002-11-19
US43855103P 2003-01-06 2003-01-06
US60/438,551 2003-01-06
US44114403P 2003-01-17 2003-01-17
US60/441,144 2003-01-17
US44313503P 2003-01-27 2003-01-27
US60/443,135 2003-01-27

Publications (2)

Publication Number Publication Date
WO2004037987A2 WO2004037987A2 (fr) 2004-05-06
WO2004037987A3 true WO2004037987A3 (fr) 2004-09-02

Family

ID=32180858

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/033491 Ceased WO2004037987A2 (fr) 2002-10-22 2003-10-22 Proteines secretees

Country Status (2)

Country Link
AU (1) AU2003286581A1 (fr)
WO (1) WO2004037987A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090075291A1 (en) * 2006-01-13 2009-03-19 The Research Foundation Of State University Of New York Peptide-based regulation of gap junctions
CN112794896B (zh) * 2021-01-12 2022-08-05 四川菲德力制药有限公司 一种胃膜素的制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001044448A2 (fr) * 1999-12-16 2001-06-21 Incyte Genomics, Inc. Proteines d'oxydoreductase humaines

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001044448A2 (fr) * 1999-12-16 2001-06-21 Incyte Genomics, Inc. Proteines d'oxydoreductase humaines

Also Published As

Publication number Publication date
AU2003286581A8 (en) 2004-05-13
WO2004037987A2 (fr) 2004-05-06
AU2003286581A1 (en) 2004-05-13

Similar Documents

Publication Publication Date Title
WO2002038602A3 (fr) Proteines secretees
WO2003027228A3 (fr) Recepteurs et proteines associees a une membrane
WO2001098353A3 (fr) Proteines secretees
WO2003048305A3 (fr) Recepteurs et proteines associees aux membranes
WO2002048337A3 (fr) Proteines secretees
WO2003029437A3 (fr) Proteines secretees
WO2002072794A3 (fr) Proteines de la superfamille des immunoglobulines
WO2001079291A3 (fr) Proteines secretees
WO2003004615A3 (fr) Proteines secretees
WO2004044165A3 (fr) Proteines associees aux lipides
WO2002097060A3 (fr) Proteines associees aux carbohydrates
WO2003070902A3 (fr) Recepteurs et proteines associees aux membranes
WO2003068943A3 (fr) Proteines secretees
WO2002070669A3 (fr) Proteines secretees
WO2002086069A3 (fr) Proteines secretees
WO2004048550A3 (fr) Proteines associees a une reponse immune
WO2003062391A3 (fr) Proteines structurelle associees au cytosquelette
WO2002026982A3 (fr) Proteines secretees
WO2003087300A3 (fr) Proteines secretees
WO2003025130A3 (fr) Recepteurs et proteines associees a la membrane
WO2002066646A3 (fr) Proteines associees a la neurotransmission
WO2003016506A3 (fr) Proteines secretees
WO2002079441A3 (fr) Proteines secretees
WO2003063769A3 (fr) Proteines associees aux vesicules
WO2001051636A3 (fr) Proteines secretees

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP